Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station [Yahoo! Finance]
Prenetics Global Limited - Class A Ordinary Share (PRE)
Company Research
Source: Yahoo! Finance
Dr. James L. Green, former Chief Scientist of NASA and Dr. Tara Ruttley , former Associate Chief Scientist of NASA to join Prenetics Scientific Advisory Board Inaugural research cube scheduled to be sent on-board SpaceX to the ISS in Q4 of 2024 HONG KONG Feb. 9, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ:PRE), a leading genomics-driven health sciences company, announces the signing of a Memorandum of Understanding (MOU), that paves the way for a strategic investment in Metavisionaries and a pioneering five-year research agreement with them and their partners Space Application Services through their Metaspace Venture. The parties will also establish a Space Innovation Lab within the UAE Space Agency. The inaugural Prenetics research cube is scheduled to on-board the SpaceX to the ISS in Q4 of 2024. Mohsen Al Alwadi , Director of the Space Missions Department at the UAE Space Agency remarked: "The UAE Space Agency is thrilled to support the initiative of the Prenetics
Show less
Read more
Impact Snapshot
Event Time:
PRE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRE alerts
High impacting Prenetics Global Limited - Class A Ordinary Share news events
Weekly update
A roundup of the hottest topics
PRE
News
- Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare movers [Seeking Alpha]Seeking Alpha
- Prenetics Global Limited (NASDAQ: PRE) had its price target lowered by analysts at Cantor Fitzgerald from $10.00 to $9.00. They now have an "overweight" rating on the stock.MarketBeat
- Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Prenetics Announces Fourth Quarter and Full Year 2023 Financial ResultsPR Newswire
PRE
Analyst Actions
- 4/4/24 - Cantor Fitzgerald
PRE
Sec Filings
- 5/1/24 - Form 20-F
- 5/1/24 - Form S-8
- 4/1/24 - Form 6-K
- PRE's page on the SEC website